HUE069364T2 - Eljárás immunglobulin variábilis egydomének elõállítására - Google Patents
Eljárás immunglobulin variábilis egydomének elõállításáraInfo
- Publication number
- HUE069364T2 HUE069364T2 HUE17192342A HUE17192342A HUE069364T2 HU E069364 T2 HUE069364 T2 HU E069364T2 HU E17192342 A HUE17192342 A HU E17192342A HU E17192342 A HUE17192342 A HU E17192342A HU E069364 T2 HUE069364 T2 HU E069364T2
- Authority
- HU
- Hungary
- Prior art keywords
- production
- variable domains
- single variable
- immunoglobulin single
- immunoglobulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40822810P | 2010-10-29 | 2010-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE069364T2 true HUE069364T2 (hu) | 2025-03-28 |
Family
ID=44872371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17192342A HUE069364T2 (hu) | 2010-10-29 | 2011-10-28 | Eljárás immunglobulin variábilis egydomének elõállítására |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20130261288A1 (index.php) |
| EP (3) | EP2632946B1 (index.php) |
| DK (2) | DK2632946T3 (index.php) |
| ES (2) | ES2996232T3 (index.php) |
| HU (1) | HUE069364T2 (index.php) |
| NO (1) | NO2632946T3 (index.php) |
| PL (2) | PL3279214T3 (index.php) |
| PT (1) | PT2632946T (index.php) |
| WO (1) | WO2012056000A1 (index.php) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2996232T3 (en) | 2010-10-29 | 2025-02-12 | Ablynx Nv | Method for the production of immunoglobulin single variable domains |
| WO2014087010A1 (en) | 2012-12-07 | 2014-06-12 | Ablynx N.V. | IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE |
| CN110845618A (zh) | 2013-02-26 | 2020-02-28 | 罗切格利卡特公司 | 双特异性t细胞活化抗原结合分子 |
| PL3294319T3 (pl) | 2015-05-13 | 2024-10-07 | Ablynx Nv | Polipeptydy rekrutujące komórki t na podstawie reaktywności cd3 |
| ES2754427T3 (es) | 2015-05-13 | 2020-04-17 | Ablynx Nv | Polipéptidos de reclutamiento de células T basados en la reactividad de TCR alfa/beta |
| CA3043515A1 (en) | 2016-11-16 | 2018-05-24 | Ablynx Nv | T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta |
| EP4126971A1 (en) | 2020-03-30 | 2023-02-08 | Ablynx N.V. | Method for the production and purification of multivalent immunoglobulin single variable domains |
| PH12023500009A1 (en) | 2020-12-18 | 2024-03-11 | Ablynx Nv | T cell recruiting polypeptides based on tcr alpha/beta reactivity |
| JP2025526384A (ja) | 2022-07-27 | 2025-08-13 | アブリンクス エン．ヴェー． | 新生児型Ｆｃ受容体の特異的エピトープに結合するポリペプチド |
| EP4665755A1 (en) | 2023-02-17 | 2025-12-24 | Ablynx N.V. | Polypeptides binding to the neonatal fc receptor |
| WO2025008537A1 (en) | 2023-07-05 | 2025-01-09 | Ablynx Nv | Improved fcrn antagonists for treatment of igg-related diseases and disorders |
| AR133903A1 (es) | 2023-09-22 | 2025-11-12 | Ablynx Nv | Agentes de unión de albúmina bi- y multivalentes |
| WO2025207946A1 (en) | 2024-03-28 | 2025-10-02 | Genzyme Corporation | Polypeptides binding to a specific epitope of the transferrin receptor 1 |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI903489A0 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Ligander med en enda sektion, receptorer innehaollande naemnda ligander, foerfaranden foer deras framstaellning samt anvaendning av liganderna och receptorerna. |
| EP1498427B1 (en) | 1992-08-21 | 2009-12-16 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| DK0698097T3 (da) | 1993-04-29 | 2001-10-08 | Unilever Nv | Produktion af antistoffer eller (funktionaliserede) fragmenter deraf afledt af Camelidae-immunoglobuliner med tung kæde |
| FR2708622B1 (fr) | 1993-08-02 | 1997-04-18 | Raymond Hamers | Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides. |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| AU740043B2 (en) | 1996-06-27 | 2001-10-25 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| EP1027439B1 (en) | 1997-10-27 | 2010-03-17 | Bac Ip B.V. | Multivalent antigen-binding proteins |
| BR9907241A (pt) | 1998-01-26 | 2000-10-17 | Unilever Nv | Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo |
| WO2000040968A1 (en) | 1999-01-05 | 2000-07-13 | Unilever Plc | Binding of antibody fragments to solid supports |
| WO2000043507A1 (en) | 1999-01-19 | 2000-07-27 | Unilever Plc | Method for producing antibody fragments |
| ID30380A (id) | 1999-04-22 | 2001-11-29 | Unilever Nv | Penghambatan infeksi virus menggunakan protein pengikat antigen bervalensi tunggal |
| US6479280B1 (en) | 1999-09-24 | 2002-11-12 | Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw | Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| DK1233987T3 (da) | 1999-11-29 | 2009-09-28 | Bac Ip B V | Immobiliserede enkelt-domæne antigenbindende molekyler |
| EP1242460B1 (en) | 1999-11-29 | 2006-10-18 | Unilever Plc | Immobilisation of proteins using a polypeptide segment |
| EP1134231B1 (en) | 2000-03-14 | 2009-04-15 | Unilever N.V. | Antibody heavy chain variable domains against human dietary lipases, and their uses |
| CA2380443C (en) | 2000-05-26 | 2013-03-12 | Ginette Dubuc | Single-domain antigen-binding antibody fragments derived from llama antibodies |
| US20040053340A1 (en) | 2000-12-13 | 2004-03-18 | De Haard Johannes Joseph | Protein arrays |
| US20060073141A1 (en) | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
| EP1433793A4 (en) | 2001-09-13 | 2006-01-25 | Inst Antibodies Co Ltd | METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| AU2002351896A1 (en) | 2001-12-11 | 2003-06-23 | Ablynx N.V. | Method for displaying loops from immunoglobulin domains in different contexts |
| WO2003062375A2 (en) | 2001-12-19 | 2003-07-31 | Genentech, Inc. | Stabilizing polypeptides which have been exposed to urea |
| AU2002360068B2 (en) | 2001-12-21 | 2009-09-03 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Method for cloning of variable domain sequences |
| JP2005517674A (ja) | 2002-01-03 | 2005-06-16 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー | 腫瘍の処置に有用な新規免疫コンジュゲート |
| AT5962U1 (de) | 2002-06-19 | 2003-02-25 | Siro Beschlaege Metall | Präsentationsvorrichtung für gegenstände |
| US20050172991A1 (en) | 2002-06-19 | 2005-08-11 | Kabushiki Kaisha Toshiba | Thermoelectric element and electronic component module and portable electronic apparatus using it |
| WO2004041862A2 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| EP1558647B1 (en) | 2002-11-08 | 2015-06-10 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| RU2357974C2 (ru) | 2003-01-10 | 2009-06-10 | Аблинкс Н.В. | Терапевтические полипептиды, их гомологи, их фрагменты и их применение для модуляции агрегации, опосредованной тромбоцитами |
| US7461263B2 (en) | 2003-01-23 | 2008-12-02 | Unspam, Llc. | Method and apparatus for a non-revealing do-not-contact list system |
| WO2005051979A1 (en) | 2003-02-21 | 2005-06-09 | Akzo Nobel N.V. | Prevention and/or delay of peptide/protein carbamylation in urea solutions utilizing non-ethylene diamine like compounds |
| JP2007521234A (ja) | 2003-08-12 | 2007-08-02 | ウィリアム エム ヤーブロー | 尋常性ざ瘡の治療薬及び使用方法 |
| ATE485307T1 (de) | 2003-11-07 | 2010-11-15 | Ablynx Nv | Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung |
| US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| AU2005293752A1 (en) | 2004-10-13 | 2006-04-20 | Ablynx N.V. | Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as Alzheimer's disease |
| AU2005325801A1 (en) | 2005-01-31 | 2006-08-03 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
| RU2464276C2 (ru) | 2005-05-18 | 2012-10-20 | Аблинкс Н.В. | Улучшенные нанотела против фактора некроза опухоли-альфа |
| DK2444424T3 (en) | 2005-05-20 | 2018-12-03 | Ablynx Nv | IMPROVED NANOL BODIES (TM) FOR TREATING AGGREGATED MEDICINAL DISORDERS |
| CA2678218A1 (en) | 2007-02-21 | 2008-08-28 | Ablynx N.V. | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| AU2008252853B2 (en) | 2007-05-24 | 2011-12-01 | Ablynx N.V. | Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders |
| US20090130105A1 (en) * | 2007-08-28 | 2009-05-21 | Biogen Idec Ma Inc. | Compositions that bind multiple epitopes of igf-1r |
| CN101970490A (zh) | 2007-11-27 | 2011-02-09 | 埃博灵克斯股份有限公司 | 针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽 |
| KR20110079693A (ko) | 2008-10-29 | 2011-07-07 | 와이어쓰 엘엘씨 | 단일 도메인 항원 결합 분자의 정제 방법 |
| AU2010233658B2 (en) | 2009-04-10 | 2013-11-28 | Ablynx Nv | Improved amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of IL-6R related diseases and disorders |
| AU2010243551B2 (en) | 2009-04-30 | 2015-03-26 | Ablynx Nv | Method for the production of domain antibodies |
| EP2438087B1 (en) | 2009-06-05 | 2017-05-10 | Ablynx N.V. | Trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| RS67588B1 (sr) | 2009-12-14 | 2026-01-30 | Ablynx Nv | Antitela sa pojedinačnim varijabilnim domenom imunoglobulina protiv ox40l, konstrukti i njihova terapijska upotreba |
| ES2996232T3 (en) | 2010-10-29 | 2025-02-12 | Ablynx Nv | Method for the production of immunoglobulin single variable domains |
-
2011
- 2011-10-28 ES ES17192342T patent/ES2996232T3/es active Active
- 2011-10-28 US US13/824,481 patent/US20130261288A1/en not_active Abandoned
- 2011-10-28 EP EP11775994.4A patent/EP2632946B1/en active Active
- 2011-10-28 EP EP17192342.8A patent/EP3279214B1/en active Active
- 2011-10-28 HU HUE17192342A patent/HUE069364T2/hu unknown
- 2011-10-28 NO NO11775994A patent/NO2632946T3/no unknown
- 2011-10-28 DK DK11775994.4T patent/DK2632946T3/en active
- 2011-10-28 PL PL17192342.8T patent/PL3279214T3/pl unknown
- 2011-10-28 ES ES11775994.4T patent/ES2660895T3/es active Active
- 2011-10-28 PT PT117759944T patent/PT2632946T/pt unknown
- 2011-10-28 EP EP24198210.7A patent/EP4458858A3/en active Pending
- 2011-10-28 DK DK17192342.8T patent/DK3279214T3/da active
- 2011-10-28 WO PCT/EP2011/068982 patent/WO2012056000A1/en not_active Ceased
- 2011-10-28 PL PL11775994T patent/PL2632946T3/pl unknown
-
2019
- 2019-08-02 US US16/529,865 patent/US12522652B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3279214B1 (en) | 2024-10-09 |
| DK3279214T3 (da) | 2024-12-09 |
| EP4458858A2 (en) | 2024-11-06 |
| EP3279214A1 (en) | 2018-02-07 |
| US20130261288A1 (en) | 2013-10-03 |
| ES2660895T3 (es) | 2018-03-26 |
| EP2632946B1 (en) | 2017-12-06 |
| US20200062834A1 (en) | 2020-02-27 |
| US12522652B2 (en) | 2026-01-13 |
| EP4458858A3 (en) | 2025-02-19 |
| EP2632946A1 (en) | 2013-09-04 |
| NO2632946T3 (index.php) | 2018-05-05 |
| PT2632946T (pt) | 2018-03-01 |
| PL2632946T3 (pl) | 2018-06-29 |
| US20200392214A9 (en) | 2020-12-17 |
| ES2996232T3 (en) | 2025-02-12 |
| PL3279214T3 (pl) | 2025-03-24 |
| DK2632946T3 (en) | 2018-03-12 |
| WO2012056000A1 (en) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2632946T3 (pl) | Sposób wytwarzania pojedynczych domen zmiennych immunoglobulin | |
| HUE051430T2 (hu) | Eljárás variábilis domének elõállítására | |
| PT2424889E (pt) | Método de produção de anticorpos de domínio | |
| PT2691415T (pt) | Método para produção de formulações sólidas compreendendo domínios variáveis únicos de imunoglobulina | |
| BR112012020964A2 (pt) | método de produção de imunoglobulina | |
| IL220404A (en) | Antiseptic antibodies | |
| ZA201300146B (en) | Process for the production of para-xylene | |
| EP2552874A4 (en) | PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE | |
| ZA201305971B (en) | Method for the purification of biphephos | |
| IL207945A0 (en) | Method for the production of carbohydrates | |
| IL249501A0 (en) | A process for creating antibodies | |
| SG10201508779UA (en) | Process for the production of paraxylene | |
| IL248217B (en) | A method for the production of inganol-3-englate | |
| EP2558432A4 (en) | METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES | |
| IL223290A (en) | Anti-1α-il antibodies for the treatment of arthritis | |
| EP2784056A4 (en) | METHOD FOR SELECTIVELY PREPARING N-METHYL-PARA-ANISIDINE | |
| IL224318B (en) | A method for the automated synthesis of small molecules | |
| LT2696959T (lt) | Aplinkai nekenksmingas cemento gamybos būdas | |
| SG11201400405TA (en) | Caninised antibodies and method for the production of same | |
| ZA201205844B (en) | Process for the production of anhydrides | |
| GB2495884B (en) | A method of increasing the effect of an activated-potentiated form of an antibody | |
| HUE044066T2 (hu) | Eljárás metilén-difenil-diizocianát elõállítására | |
| IL229375A0 (en) | A method for diagnosing rheumatoid arthritis | |
| PL393525A1 (pl) | Sposób wytwarzania rury z tworzywa termoplastycznego | |
| IL230159A0 (en) | Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide |